NO20080372L - Pyrazole derivatives as therapeutic agents - Google Patents

Pyrazole derivatives as therapeutic agents

Info

Publication number
NO20080372L
NO20080372L NO20080372A NO20080372A NO20080372L NO 20080372 L NO20080372 L NO 20080372L NO 20080372 A NO20080372 A NO 20080372A NO 20080372 A NO20080372 A NO 20080372A NO 20080372 L NO20080372 L NO 20080372L
Authority
NO
Norway
Prior art keywords
therapeutic agents
pyrazole derivatives
diarylpyrazole
carboxamides
psychiatric
Prior art date
Application number
NO20080372A
Other languages
Norwegian (no)
Inventor
Henrik Sorensen
Matti Ahlqvist
Leifeng Cheng
Robert Lundqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20080372L publication Critical patent/NO20080372L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Salter av 1,5-diarylpyrazol-3-karboksamider og prosesser for fremstilling av slike forbindelser, anvendelse av dem ved behandling av fedme, psykiatriske og nevrologiske lidelser, til metoder for deres terapeutiske anvendelse og til farmasøytiske preparater inneholdende dem.Salts of 1,5-diarylpyrazole-3-carboxamides and processes for the preparation of such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods of their therapeutic use and to pharmaceutical preparations containing them.

NO20080372A 2005-08-13 2008-01-21 Pyrazole derivatives as therapeutic agents NO20080372L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0516661.6A GB0516661D0 (en) 2005-08-13 2005-08-13 Therapeutic agents
PCT/GB2006/002990 WO2007020388A1 (en) 2005-08-13 2006-08-09 Pyrazole derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
NO20080372L true NO20080372L (en) 2008-04-16

Family

ID=35098275

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080372A NO20080372L (en) 2005-08-13 2008-01-21 Pyrazole derivatives as therapeutic agents

Country Status (18)

Country Link
EP (1) EP1915364A1 (en)
JP (1) JP2009504717A (en)
KR (1) KR20080039939A (en)
CN (1) CN101282963A (en)
AR (1) AR055368A1 (en)
AU (1) AU2006281300A1 (en)
BR (1) BRPI0614626A2 (en)
CA (1) CA2619228A1 (en)
EC (1) ECSP088250A (en)
GB (1) GB0516661D0 (en)
IL (1) IL188759A0 (en)
MX (1) MX2008002065A (en)
NO (1) NO20080372L (en)
RU (1) RU2008108179A (en)
TW (1) TW200728300A (en)
UY (1) UY29741A1 (en)
WO (1) WO2007020388A1 (en)
ZA (1) ZA200800698B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008015032A1 (en) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituted pyrazolamides and their use
DE102008015033A1 (en) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituted (pyrazolyl-carbonyl) imidazolidinones and their use
DE102008062878A1 (en) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituted furancarboxamides and their use
DE102008062863A1 (en) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituted (thiophenyl-carbonyl) imidazolidinones and their use
DE102009036604A1 (en) 2009-07-30 2011-02-03 Aicuris Gmbh & Co. Kg Substituted bis-arylpyrazolamides with terminal primary amide functionality and their use
DE102011055815A1 (en) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamide-substituted heteroaryl-pyrazoles and their use
DE102012016908A1 (en) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris (hetero) aryl-pyrazoles and their use
CN105061227A (en) * 2015-07-27 2015-11-18 广东先强药业有限公司 Environment-friendly ritodrine hydrochloride production method
WO2020123855A1 (en) 2018-12-12 2020-06-18 University Of Washington Inhibitor compounds for male contraception

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE538097T1 (en) * 2002-12-02 2012-01-15 Astellas Pharma Inc PYRAZOLE DERIVATIVES SUITABLE AS COX-I INHIBITORS
US7247628B2 (en) * 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
ATE440085T1 (en) * 2004-02-20 2009-09-15 Astrazeneca Ab 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE DERIVATIVES SUITABLE AS CB1 MODULATORS

Also Published As

Publication number Publication date
WO2007020388A1 (en) 2007-02-22
AU2006281300A1 (en) 2007-02-22
IL188759A0 (en) 2008-08-07
GB0516661D0 (en) 2005-09-21
BRPI0614626A2 (en) 2012-12-04
ECSP088250A (en) 2008-04-28
KR20080039939A (en) 2008-05-07
MX2008002065A (en) 2008-04-16
UY29741A1 (en) 2007-03-30
EP1915364A1 (en) 2008-04-30
JP2009504717A (en) 2009-02-05
CA2619228A1 (en) 2007-02-22
RU2008108179A (en) 2009-09-20
TW200728300A (en) 2007-08-01
ZA200800698B (en) 2009-01-28
CN101282963A (en) 2008-10-08
AR055368A1 (en) 2007-08-22

Similar Documents

Publication Publication Date Title
NO20080372L (en) Pyrazole derivatives as therapeutic agents
NO20080969L (en) 1,2-diarylimidazoles for use as CBI modulators
NO20064974L (en) therapeutic agents
NO20063787L (en) Therapeutic preparations
NO20055919L (en) 3-Substituted, 5,6-Diaryl-Pyrazine-2-Carboxamide and 2-Sulfonamide Derivatives as CB1 Modulators
NO20045301L (en) Substituted 1,3-diphenylprop-2-en-1-one derivative, preparation and use thereof.
NO20064201L (en) Glucopyranosyl substituted benzene derivatives, drugs containing such compounds, their use and preparation
TW200504034A (en) Therapeutic agents
NO20081523L (en) Preparation and Use of Tetrahydropyrrolo (3,2-C) Pyridin-4-One Derivatives for the Treatment of Obesity, Psychiatric and Neurological Disorders
NO20084496L (en) Pyridyl and pyrimidinyl substituted pyrrole, thiophene and furan derivatives as kinase inhibitors
NO20071915L (en) Diaminotriazole compounds useful as protein kinase inhibitors
TNSN06053A1 (en) 6-substituted anilino purines as rtk inhibitors
NO20085373L (en) P38 inhibitors, their preparation and use
DK1636236T3 (en) Pyrazolo-quinazoline derivatives, a process for their preparation, and their use as kinase inhibitors
TW200615266A (en) Organic compounds
WO2008002245A3 (en) Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
NO20082508L (en) Aminopyrimidines useful as kinase inhibitors
TW200635903A (en) Therapeutic agents
NO20070576L (en) New hydantion derivatives for the treatment of obstructive airway diseases.
NO20084747L (en) Tetrahydropteridines useful as inhibitors of protein kinases
NO20065936L (en) Sulfonylethyl phosphorus diamides for use in the treatment of cancer.
NO20081844L (en) Therapeutic compounds
NO20070570L (en) Compounds.
NO20073113L (en) Indenyl derivatives and their use for the treatment of neurological disorders
TW200633986A (en) Therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application